Evidence map›Paper›PMID 38335658›Full record

ArticleInternational immunopharmacology2024

Development of an in vitro peptide-stimulated T cell assay to evaluate immune effects by cannabinoid compounds.

Olivia Cresswell, Karis Blankenship, Barbara L F Kaplan

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International immunopharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Olivia CresswellCenter for Environmental Health Sciences, Department of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, MS, United States.
Karis BlankenshipCenter for Environmental Health Sciences, Department of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, MS, United States.
Barbara L F KaplanCenter for Environmental Health Sciences, Department of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, MS, United States. Electronic address: bkaplan@cvm.msstate.edu.
Mississippi State University · USCenter for Environmental Health · US

Funding

Zinc dependent conformational changes in AdcR and their impact on DNA bindingP20GM103646 · NIGMS · MISSISSIPPI STATE UNIVERSITY · PI NANDURI, BINDU · 2013 to 2022
$21.1M
Summer Research Experience for Veterinary StudentsT35OD010432 · OD · MISSISSIPPI STATE UNIVERSITY · PI Barbara Lee-Faubert Kaplan, Temesgen Samuel · 2012 to 2026
$1.3M
NIGMS NIH HHS P20 GM103646NIH HHS T35 OD010432
6 · The paper itself

Abstract

Previous studies demonstrated that cannabinoids exhibit immunosuppressive effects in experimental autoimmune encephalomyelitis (EAE), the animal model of multiple sclerosis (MS). To ask questions about treatment timing and investigate mechanisms for immune suppression by the plant-derived cannabinoids, cannabidiol (CBD) and Δ

Indexed as

CannabidiolCannabinoidsEncephalomyelitis, Autoimmune, ExperimentalMultiple SclerosisAnimalsCalciumCytokinesMiceMice, Inbred C57BLMyelin-Oligodendrocyte GlycoproteinPeptide FragmentsCalciumCannabidiolCannabinoidsCytokinesMyelin-Oligodendrocyte GlycoproteinPeptide FragmentsCannabinoidsImmunotoxicologyT cells

Identifiers

PMID38335658
PMCPMC10903979
OpenAlexW4391737925

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.